Table 1 Description of the seven pregnant cervical cancer patients
From: PET/MR imaging for the evaluation of cervical cancer during pregnancy
Case | Stage | PET-MRI | Pathology | Treatment | Outcome | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GA at PET-MRI, wk | SUV max | stage | histology | tumor size, mm | LVSI | pelvic LN metastasis | surgical procedure | GA at surgery, wk | GA at termination, wk | Adjuvant treatment | status | Period after surgery, y | |||
cervical cancer | pelvic LN | ||||||||||||||
#1 | IB1 | 13 + 1 | 4.5 | – | pT1b1N0 | SCC | 18 | – | 0/32 | ART-DP | 15 + 6 | 33 + 4 | Cx | NED | 5.6 |
#2 | IB1 | 9 + 1 | 8.4 | – | pT1b1N0 | adenocarcinoma | 22 | – | 0/15 | ART-DP | 15 + 1 | 37 + 1 | – | NED | 5.1 |
#3 | IB1 | 15 + 6 | 6.6 | – | pT1b1N0 | SCC | 15 | – | 0/24 | ART-DP | 17 + 0 | 33 + 0 | – | NED | 4.1 |
#4 | IB1 | 13 + 0 | 10 | – | pT1b1N0 | SCC | 20 | – | 0/30 | ART-DP | 15 + 4 | 37 + 3 | – | NED | 3.1 |
#5 | IB1 | 18 + 3 | 6.4 | – | pT1b1N0 | SCC | 30 | ly (+) | 0/22 | C/S and ARH | 31 + 4 | 31 + 4 | Cx | NED | 5.5 |
24 + 2 | 7 | – | |||||||||||||
#6 | IIIC | 14 + 5 | 16 | 8 | pT1b1N1 | adenosquamous carcinoma | 28 | ly (+) | 2/27 | ARH | 16 + 3 | 16 + 3 | CCRT | NED | 3.0 |
#7 | IA1 | 14 + 5 | – | – | pT1A1 | SCC | 2 | – | – | conization | 16 + 3 | 39 + 6 | – | NED | 2.8 |